Latest News

  • RESEARCH

    7 Nov 2025

    Nanoform and Takeda Bet on Miniature Science
  • INNOVATION

    5 Nov 2025

    The Next Big Breakthrough in Biologics Starts at Home
  • INVESTMENT

    3 Nov 2025

    Pill Power: Lexaria’s $4M Shot at Ending Injections
  • INNOVATION

    31 Oct 2025

    Biologics in Minutes: Halozyme Bets Big on Speed

The Tiny Tech Turning Biologics Into Simple Shots

The Tiny Tech Turning Biologics Into Simple Shots

TECHNOLOGY

29 Oct 2025

Acquisition of Electrofi adds next-gen drug formulation and smart injection technology to Halozyme’s tech portfolio

The Science Behind Turning Needles Into Pills

RESEARCH

24 Oct 2025

The Science Behind Turning Needles Into Pills

Researchers race to make complex injectable drugs work in pill form.

Cancer Care in a Minute: Merck’s Keytruda Revolution

INNOVATION

17 Oct 2025

Cancer Care in a Minute: Merck’s Keytruda Revolution

Merck’s new Keytruda shot cuts treatment time to a minute, transforming care deliver

Halozyme’s Elektrofi Move Redraws the Map for Drug Delivery

MARKET TRENDS

16 Oct 2025

Halozyme’s Elektrofi Move Redraws the Map for Drug Delivery

A push to make high-dose biologics easier and faster to deliver

The $900M Shot at Reinventing Biologic Delivery

TECHNOLOGY

15 Oct 2025

The $900M Shot at Reinventing Biologic Delivery

Halozyme’s Elektrofi deal could turn complex infusions into quick, patient-friendly injections

Biologic Breakthrough or Bet? Axio and Likarda Join Forces

PARTNERSHIPS

14 Oct 2025

Biologic Breakthrough or Bet? Axio and Likarda Join Forces

New partnership weaves delivery into early biologic design, sparking cautious optimism for future impact

Wearables and Biologics Push Care Beyond the Clinic

INSIGHTS

13 Oct 2025

Wearables and Biologics Push Care Beyond the Clinic

US firms pioneer wearable and greener drug-delivery systems as biologics reshape patient care

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.